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Abstract In female rats, apoptotic cell death in the corpus
luteum is induced by the prolactin (PRL) surge occurring in the
proestrous afternoon during the estrous cycle. We have
previously shown that this luteolytic action of PRL is mediated
by the Fas/Fas ligand (FasL) system. During pregnancy or
pseudopregnancy, apoptosis does not occur in the corpus luteum.
Progesterone (P4), a steroid hormone secreted from luteal
steroidogenic cells, attenuated PRL-induced apoptosis in cul-
tured luteal cells in a dose-dependent manner. P4 significantly
decreased the expression of mRNA of Fas, but not FasL, in
cultured luteal cells prepared from both proestrous and mid-
pseudopregnant rats. These data indicate that P4 suppresses
PRL-induced luteal cell apoptosis via reduction of the expression
level of Fas mRNA in the corpus luteum, suggesting that P4 acts
as an important factor that can change the sensitivity of corpus
luteum to PRL.
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1. Introduction
Apoptosis, a form of programmed or physiological cell
death, allows tissue remodeling and cellular replacement to
occur rapidly without damaging surrounding tissue [1]. One
of the physiological processes in which apoptosis takes place
is the regression of the corpora lutea in the ovary [2]. In rats,
when pregnancy fails to occur, the corpora lutea should be
rapidly removed from the ovary for induction of the next
ovulation. We have previously found that luteolysis (the re-
gression of the corpus luteum) in rats is associated with the
occurrence of fragmented DNA degeneration, a hallmark of
apoptosis, and that this degeneration depended on the pres-
ence of endogenous surge levels of PRL [3,4].
Recent observations have revealed an involvement of the
Fas/APO-1/CD95 (Fas) and Fas ligand (FasL) system with
reproductive tissue remodeling [5^12]. Fas is a cell surface
molecule that mediates apoptosis-inducing signals by stimula-
tion with Fas ligand or agonistic anti-Fas antibody [13]. Large
amounts of Fas protein and mRNA have been detected in
mammalian reproductive as well as immune tissues [7^
10,14,15]. Treatment with anti-Fas antibody has been shown
to induce apoptosis in human and mice primary cultured cells
prepared from corpora lutea [7,16] and to enhance both fol-
licular atresia and structural luteolysis in vivo [8,9]. Our recent
studies have demonstrated that PRL-induced luteal steroido-
genic cell apoptosis also involves the Fas/FasL system in rats
[17]. FasL expression is enhanced by PRL in cultured rat
luteal immune cells, and PRL-induced luteal steroidogenic
cell apoptosis is inhibited by the addition of anti-FasL anti-
body that neutralizes FasL function, indicating that the Fas/
FasL system plays a crucial role in the luteolysis initiated by
PRL.
Once pregnancy or pseudopregnancy is introduced in fe-
male rats, however, the corpus luteum does not undergo
apoptosis against endogenous PRL surges until termination
of the pregnancy/pseudopregnancy [18^23]. The corpus lu-
teum contains many luteal steroidogenic cells with hyper-
plastic and hypertrophic features that continuously secrete
progesterone (P4) for the maintenance of pregnancy/pseudo-
pregnancy. We have revealed that the addition of PRL to
primary cultured luteal cells prepared from these pseudopreg-
nant female rats fails to induce apoptosis [4]. Thus, luteal
steroidogenic cells in pregnancy seem resistant against the
apoptotic action of PRL, whereas these corpora lutea during
the estrous cycle rapidly regressed and eventually disappeared
as a result of apoptotic processes by PRL. Therefore, the issue
is what determines the tissue and cell fate of corpus luteum in
between the estrous cycle and pregnancy/pseudopregnancy,
especially in terms of the response against the apoptotic func-
tion of PRL.
In the present study, we revealed that P4 acts as an impor-
tant factor that changes the sensitivity of the corpus luteum to
PRL. P4 suppresses PRL-induced luteal steroidogenic cell
apoptosis via a reduction of the expression levels of Fas
mRNA in the corpus luteum, suggesting the existence of an
autonomous tissue/cell fate decision mechanism in the regres-
sion of corpus luteum.
2. Materials and methods
2.1. Animals
Adult female Wistar rats purchased from Imamichi Institute for
Animal Reproduction (Omiya, Japan) (12 weeks old, 313.1 þ 5.8 g
body weight (BW)) were housed under a controlled lighting condition
of 14 h light and 10 h darkness for 1^2 months (lights on 05:00^19:00
h). All animals received human care as outlined in the ‘Guide for the
Care and Use of Animals’ (Tokyo University Animal Care Committee
according to NIH #86-23; revised 1985). Vaginal cytological exami-
nations were carried out every day, and only those animals showing
consecutive regular 4-day cycles were used. Luteal cells were obtained
from 8- to 14-week-old rats on the proestrous day as previously de-
scribed [17]. Pseudopregnancy was induced by cervical stimulation
with a glass rod between 18:00^19:00 h on the proestrous day, and
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the next day (the day of estrus) was designated as day 1 of pseudo-
pregnancy.
2.2. Cell preparation, culture, and assay for cell viability
Cells were prepared from corpora lutea by a modi¢ed method of
Kuranaga et al. [17]. In our preparation method, ‘luteal cells’ contain
both steroidogenic cells and immune cells. To examine the rate of
steroidogenic cells in luteal cells prepared from rat corpora lutea,
we used 3L-hydroxysteroid dehydrogenase (3L-HSD) activity staining,
as described above [17]. The rate of steroidogenic cells was 39.2 þ 1.8%
in luteal cells. For the cell viability assay, the number of viable cells
was assessed using a Dojindo Cell Counting Kit including WST-1
(Dojindo), a kind of MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium/Br), as previously described [17]. In this assay, data
are expressed as the percentage of the appropriate control values.
2.3. Detection of fragmented DNA by gel electrophoresis
The metestrous and diestrous rats were given s.c. injections (15:00
h, 16:00 h and 17:00 h) with PRL (ovine PRL; Sigma; 667 Wg/kg
BW) or saline. A dose of PRL was used as determined in previous
studies by Day et al. [22]. Approximately 30 corpora lutea were col-
lected and weighed at 18:00 h on the metestrous and diestrous days.
Fragmented DNA was isolated and analyzed by a previously reported
method [3,24,25]. Densitometric analysis of low molecular weight
DNA was performed with an Image Scanner (EU10, Epson Co.,
Tokyo, Japan) with NIH Image 1.57 software (Wayne Rasband, Na-
tional Institute of Health, USA) as previously described [9]. The trials
were repeated more than three times for each sample, and represen-
tative results are shown.
2.4. Detection of Fas and FasL mRNA by RT-PCR
Expression of Fas and FasL mRNA in the cultured luteal cells was
con¢rmed using RT-PCR. The primer sets for rat Fas (5P-GTG ATG
AAG GGC ATG GTT-3P and 5P-TTG ACA CGC ACC AGT CTT-
3P) and rat FasL (5P-CCA GAT CTA CTG GGT AGA-3P and 5P-
ATG GTC AGC AAC GGT AAG-3P) were used. The reaction mix-
tures were heated at 95‡C for 10 min, followed by 35 cycles of am-
pli¢cation steps carried out at 94‡C for 1 min, 55‡C for 1 min, and
72‡C for 2 min. The samples were then incubated at 72‡C for 10 min.
The expected sizes of the PCR products were 546 bp (rat Fas) and
698 bp (rat FasL). The equality of the amount of cDNA samples used
for PCR of rat Fas and FasL was veri¢ed by PCR using the primer
set of rat L-actin (Research Genetics, Inc) (PCR cycle: 25 cycles).
Quantitative analysis of the expression of Fas, FasL and L-actin
mRNA were performed on the photo of the gel using NIH image
software.
2.5. Statistical analysis
The Student’s t-test was used for statistical evaluation of all the
results. Di¡erences of P6 0.05 were considered statistically signi¢-
cant.
3. Results and discussion
3.1. Luteal cells in each estrous cycle stage exhibit di¡erent
response against PRL
In cycling female rat, the corpus luteum is formed on the
day of estrus, and serum P4 levels start increasing on the next
day (metestrus), rapidly decrease upon the start of diestrus,
and then remain low during proestrus (Scheme 1). When preg-
nancy/pseudopregnancy is achieved by mating, the corpus lu-
teum becomes fully functional for P4 secretion and contains
many hypertrophic and hyperplastic luteal cells. These func-
tional corpora lutea lose their sensitivity to PRL surges, which
can cause luteolysis [4] (Scheme 1). We hypothesized that such
a completely di¡erent response of corpus luteum against PRL
might be modulated by some of the hormones that regulate
the female estrous cycle like LH, FSH, estrogen, androgen,
P4, GnRH, and so on. To test this possibility, the luteal cells
were prepared on the day of proestrus, metestrus, and dies-
trus, and we then examined whether the luteolytic action of
PRL on the cells during proestrus could be reproduced in the
cells at other stages of the estrous cycle. Consistent with pre-
viously reported data [3,17], the addition of PRL caused a
signi¢cant decrease in the viability of proestrous luteal cells
(proestrus 09:00, 12:00, and 18:00 h; Fig. 1). Because we
were able to observe a similar apoptotic e¡ect of PRL on
luteal cells prepared from diestrous female rats (diestrus
18:00 h; Fig. 1), we concluded that a stage-speci¢c endocrine
milieu in vivo is not involved in this apoptotic process initi-
ated by PRL. However, PRL could reproduce an apoptotic
cell death process in luteal cells of diestrus (diestrus 18:00 h;
Fig. 1), but not metestrus (metestrus 18:00 h; Fig. 1), suggest-
ing that apoptosis inhibitory mechanisms against PRL-in-
duced luteolysis may exist in the metestrous corpus luteum.
3.2. PRL can induce apoptosis in the corpus luteum in the
diestrous stage, but not in metestrus in vivo
To examine these observations precisely, we intended to
inject PRL into female rats and recover corpora lutea for
evaluating the amounts of fragmented DNA. Injection of
PRL on the day of diestrus signi¢cantly induced DNA frag-
mentation in the corpora lutea, but the corpora lutea on the
metestrous day failed to undergo apoptosis in response to
PRL treatment (Fig. 2). These data clearly indicated that
the critical point at which the cell/tissue fate of corpus luteum
divides between survival and regression should be in between
metestrus (18:00 h) and diestrus (18:00 h). One of the hormo-
nal events that occurs during this limited period is a decrease
in serum P4 levels (Scheme 1), and this leads us to hypothesize
that P4 may be involved in the regulations of corpus luteum
regression, especially the execution of luteal cell apoptosis.
3.3. P4 inhibits PRL-induced apoptosis in luteal cells
Our observations described above initially suggested that P4
can function to suppress the occurrence of apoptosis induced
by PRL in the corpus luteum. To examine this possibility, P4
Scheme 1. A scheme for the fate of corpus luteum in relation to the
serum concentrations of serum P4 levels based on a report by Smith
et al. [23] in the cycling rat (a solid line) and the pregnant rat (a
dotted line). A: First, ovulation occurs at the estrous stage. B: Sec-
ond, luteinization, the formation of the corpus luteum, is observed
in the ovary after ovulation. C: In the case of a successful mating,
the corpus luteum maintains P4 secretion (functional corpus lu-
teum). D: In a normal estrous cycle, the serum P4 level is rapidly
decreased during the diestrous afternoon, and corpus luteum begins
to regress following the PRL surge at the proestrous stage.
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was added with PRL to primary luteal cells prepared from the
proestrous (18:00 h) rat. As shown in Fig. 3, PRL-induced
luteal cell apoptosis was signi¢cantly suppressed by the addi-
tion of P4 in a dose-dependent manner. In this result, because
PRL-induced luteal cell apoptosis was observed to be e¡ec-
tively suppressed by P4, the ability of luteal cells to secrete P4
would determine whether the corpus luteum survived or re-
gressed. In female rats, functional regression of the corpus
luteum with a decrease in serum P4 concentrations begins
within 2^3 days after ovulation by an acute increase in the
activity of 20K-hydroxysteroid dehydrogenase (20K-HSD),
which catabolizes P4 into an inactive steroid, 20K-dihydropro-
gesterone [26]. Therefore, luteal cells expressing active 20K-
HSD are likely to be functionally and fatally ‘dead cells’
that should be eliminated via apoptosis induced by the PRL
surge that occurs on the day of proestrus.
3.4. P4 downregulates Fas mRNA expression in proestrous
luteal cells
We next tried to determine how P4 suppresses PRL-induced
luteal cell apoptosis. We previously observed that PRL stim-
ulates the expression of FasL on luteal immune cells, and the
Fas-expressing luteal steroidogenic cells are induced to apop-
tosis by this FasL ([17] and our unpublished results). Thus,
based on these results, we hypothesized that P4 may a¡ect the
expression levels of Fas or FasL in the cells of the corpus
luteum. To elucidate this hypothesis, semi-quantitative RT-
PCR for the detection of Fas and FasL mRNA was per-
formed on cultured luteal cells. In primary luteal cell culture
prepared from a proestrous (18:00 h) female rat, both Fas
and FasL mRNA were expressed abundantly at a 0 h culture
period (Fig. 4A). When luteal cells were incubated with P4 (2
Wg/ml) for 24 h, the Fas expression, but not FasL, was dra-
matically reduced by the addition of P4 (Fig. 4A), indicating
that P4 has an ability to downregulate Fas mRNA expression
in the cells of the corpus luteum. In each experiment, there
was no observable change in L-actin mRNA levels (Fig. 4A
and B).
3.5. Fas mRNA expression is increased by the withdrawal of P4
in pseudopregnant luteal cells
We next prepared primary luteal cells from the mid-pseu-
dopregnant female rat, in which serum concentrations of P4
were maintained at high levels because 20K-HSD activity in
the corpus luteum is signi¢cantly suppressed [18^22]. At a 0 h
culture period, the levels of Fas and FasL mRNA expression
were revealed to be low in pseudopregnant luteal cells (Fig.
4B). The amount of Fas mRNA was remarkably increased
when these luteal cells were cultured without P4 for 24 h
and 48 h, suggesting that Fas expression in corpus luteum
may be suppressed by high concentrations of serum P4 in
the mid-pseudopregnant female rat. Actually, the Fas
mRNA expression remained at low levels with the continuous
addition of P4 into the culture medium. Thus, these observa-
tions suggest that P4 suppresses the PRL-induced luteal ster-
oidogenic cell apoptosis by the downregulation of Fas expres-
sion.
Based on these results, an outline of a predicted mechanism
for luteolysis, speci¢cally a regression of the corpus luteum,
can be described as follows: ¢rst, the steroidogenic cells in the
Fig. 2. PRL induces apoptosis in the corpus luteum at the diestrous,
but not the metestrous, stage in vivo. The donor rats were pre-
treated three times by injection (15:00 h, 16:00 h, and 17:00 h) of
either PRL (667 Wg/kg BW) or saline alone as control. Samples
were collected each day at 18:00 h, and a performed densitometric
analysis of the electrophoresed DNA fragments was performed. The
relative amount of fragmented DNA at diestrus 18:00 h (PRL3)
was taken as 100%. (mean þ S.E.M., n = 4, *P6 0.05).
Fig. 3. P4 inhibits PRL-induced apoptosis in luteal cells. A dose-de-
pendent e¡ect of P4 was observed on the viability of cultured luteal
cells prepared from corpora lutea at proestrus 18:00 h. Luteal cells
were cultured for 24 h in the presence of graded concentrations of
P4. After this treatment, the culture medium was changed, and lu-
teal cells were cultured with PRL (2 Wg/ml) in the presence of each
concentration of P4. The cell viability was measured by MTT assay.
The results are expressed as percentages of the average viability in
control cells cultured with the vehicle (mean þ S.E.M., n = 8,
*P6 0.05 vs. +PRL/3P4).
Fig. 1. Luteal cells in each estrous cycle stage exhibit di¡erent re-
sponses against PRL. Stage-dependent e¡ects of PRL on the viabil-
ity of cultured luteal cells prepared from corpora lutea at each stage
(M: metestrus 18:00 h, D: diestrus 18:00 h, proestrus 09:00 h,
12:00 h, 18:00 h) in the estrous cycle. Luteal cells were cultured for
24 h in the presence of PRL (2 Wg/ml). The cell viability was meas-
ured by MTT assay. The results are expressed as percentages of the
average viability of the control cells cultured without PRL (mean þ
S.E.M., n = 4, *P6 0.01).
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corpus luteum, which exhibit 20K-HSD activity and lose their
P4-secreting ability, begin to express Fas on their surface;
second, PRL binds to its receptor on luteal immune cells
and induces the expression of FasL on the surface of these
kind of cells ([17] and our unpublished results) ; and third,
FasL-expressing immune cells interact with Fas-expressing
steroidogenic cells and induce apoptotic cell death in these
steroidogenic cells [17].
Thus, in the mechanism of rat luteal regression, the level of
P4 concentration determines the fate of corpus luteum by
downregulating Fas expression, suggesting the novel cell-
autonomous regulation of physiological cell death.
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Fig. 4. P4 downregulates Fas mRNA expression in luteal cells. Semi-quantitative RT-PCR analysis of the expression of rat Fas and FasL
mRNA in the cultured luteal cells. A: Expressions of Fas and FasL mRNA in cultured luteal cells from female rats at the day of proestrus
18:00 h. Luteal cells were cultured for 0 h (left panel), and 24 h (right panel) in the presence of P4 (2 Wg/ml). Control cells were cultured with
the vehicle. RT-PCR was performed by using speci¢c primers for the detection of rat Fas and FasL. These signals were normalized to the L-ac-
tin internal control for each sample (lower panel). The quanti¢cation data (the ratio of Fas and FasL to each L-actin PCR produces) are ex-
pressed as the ratio to the average amount in samples taken at 3P4. Data points represent the mean þ S.E.M. of four separate experiments
(*P6 0.01 vs. 3P4). B: Expressions of Fas and FasL mRNA in cultured luteal cells from mid-pseudopregnant rats (day 6). Luteal cells were
cultured for 0 h (left panel), 24 h (middle panel), and 48 h (right panel) in the presence of P4, as described in A.
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